NeuroFrance 2023

📢”GLUNOMAB IMMUNOTHERAPY: A NOVEL MECHANISM OF ACTION FOR THE TREATMENT OF PARKINSON’S DISEASE”

Lys Therapeutics is presenting during the International #NeuroFrance meeting organized by the French Society of Neurosciences (Société des Neurosciences) its last preclinical results in #Parkinson‘s Disease generated in collaboration with the University of Michigan, US.

Meet Dr. Nathalie Delétage and Dr. Flavie Lesept, R&D Program Manager, and Dr. Fanny Potzeha, R&D Project Manager.

📅 May 24-26, 2023
📍 Lyon, France

With Pr Daniel Lawrence, University of Michigan, Institut BB@C – Blood and Brain @ Caen normandie